1,4-dimethoxy-3-bromo-2-hydroxymethylnaphthalene | 289896-64-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1,4-dimethoxy-3-bromo-2-hydroxymethylnaphthalene
• 英文别名: (3-bromo-1,4-dimethoxynaphthalen-2-yl)methanol
• CAS: 289896-64-6
• 化学式: C₁₃H₁₃BrO₃
• 分子量: 297.148
• InChiKey: GJZOYDSVBUMZOV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1,4-dimethoxy-3-bromo-2-hydroxymethylnaphthalene 在 三溴化磷 作用下， 以 四氯化碳 为溶剂， 反应 1.0h， 以66%的产率得到2-bromo-3-(bromomethyl)-1,4-dimethoxynaphthalene
  参考文献：
  名称：

  分子内Heck反应合成五聚体及C（1）-和C（3）-取代的五聚体

  摘要：

  使用分子内Heck反应作为关键步骤，已经证明了一种高效且高产的五肽酮和1-烷基，1-芳基和3-烷基取代的五肽酮的合成途径。

  DOI：

  10.1016/j.tetlet.2012.03.061
• 作为产物：
  描述：

  1,4-二甲氧基萘-2-甲醛 在 sodium tetrahydroborate 、 溴 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 3.0h， 生成 1,4-dimethoxy-3-bromo-2-hydroxymethylnaphthalene
  参考文献：
  名称：

  分子内Heck反应合成五聚体及C（1）-和C（3）-取代的五聚体

  摘要：

  使用分子内Heck反应作为关键步骤，已经证明了一种高效且高产的五肽酮和1-烷基，1-芳基和3-烷基取代的五肽酮的合成途径。

  DOI：

  10.1016/j.tetlet.2012.03.061

文献信息

• An efficient synthesis of 4-isochromanones via Parham-type cyclization with Weinreb amide
  作者：Chaolei Wang、Zheng Wu、Jia Wang、Jie Liu、Hequan Yao、Aijun Lin、Jinyi Xu

  DOI：10.1016/j.tet.2015.08.028

  日期：2015.10

  The synthesis of 4-isochromanones via Parham-type cyclization with Weinreb amide as the internal electrophilic group, t-BuLi as the lithium reagent was described. The reaction was efficient and could be completed in one minute. The application scope of this new protocol was investigated and the desired products could be obtained in good to excellent yields. Besides, the synthetic potential of this

  4-异色满酮类经由帕海姆型环化的Weinreb合成酰胺作为内部电子基团，吨正丁基锂作为被描述的锂试剂。该反应是有效的，并且可以在一分钟内完成。这个新的协议的应用范围进行了研究和所需产物可以以良好地获得优异的产率。此外，该方法的合成潜力还通过天然产物（±）-XJP的合成得到了进一步证明，该合成是通过六个步骤获得的，总收率高达54％。
• Phosphoramide compounds
  申请人：——

  公开号：US20030008850A1

  公开（公告）日：2003-01-09

  The invention provides a compound of formula I: 1 wherein R 1 , R a , R b , R c , and R d have any of the values defined in the specification, as well as pharmaceutical compositions comprising such compounds or salts. The compounds are useful for treating cancer in animals.

  本发明提供了一种I式化合物：1，其中R1、Ra、Rb、Rc和Rd的任何值均定义在规范中，以及包含这种化合物或盐的药物组合物。这些化合物对于治疗动物的癌症具有用处。
• Quinone derivatives, pharmaceutical compositions, and uses thereof
  申请人：Kelley Mark R.

  公开号：US09089605B2

  公开（公告）日：2015-07-28

  This application describes quinone derivatives which target the redox site of Ape1/Ref1. Also included in the invention are pharmaceutical formulations containing the derivatives and therapeutic uses of the derivatives.

  本申请描述了靶向Ape1/Ref1的氧化还原位点的醌衍生物。本发明还包括含有该衍生物的药物配方和该衍生物的治疗用途。
• QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
  申请人：Kelley Mark R.

  公开号：US20100297113A1

  公开（公告）日：2010-11-25

  This application describes quinone derivatives which target the redox site of Ape1/Ref1. Also included in the invention are pharmaceutical formulations containing the derivatives and therapeutic uses of the derivatives.

  这个应用描述了目标为Ape1/Ref1的氧化还原位点的醌衍生物。发明还包括含有这些衍生物的药物制剂和这些衍生物的治疗用途。
• Development of Novel Quinone Phosphorodiamidate Prodrugs Targeted to DT-Diaphorase
  作者：Carolee Flader、Jiwen Liu、Richard F. Borch

  DOI：10.1021/jm000179o

  日期：2000.8.1

  A series of naphthoquinone and benzimidazolequinone phosphorodiamidates has been synthesized and studied as potential cytotoxic prodrugs activated by DT-diaphorase. Reduction of the quinone moiety in the target compounds was expected to provide a pathway for expulsion of the phosphoramide mustard alkylating agent. All of the compounds synthesized were excellent substrates for purified human DT-diaphorase (k(cat)/K-m = 3 x 10(7) - 3 x 10(8) M-1 s(-1)). The naphthoquinones were toxic to both HT-29 and BE human colon cancer cell lines in a clonogenic assay; however, cytotoxicity did not correlate with DT-diaphorase activity in these cell lines. The benzimidazolequinone analogues were 1-2 orders of magnitude less cytotoxic than the naphthoquinone analogues. Chemical reduction of the naphthoquinone led to rapid expulsion of the phosphorodiamidate anion; in contrast, the benzimidazole reduction product was stable. Michael addition of glutathione and other sulfur nucleophiles provides an alternate mechanism for activation of the naphthoquinone phosphorodiamidates, and this mechanism may contribute to the cytotoxicity of these compounds.